A significant Infection Control warning has been declared in Karachi, Pakistan’s principal commercial and banking hub. This alert occurred in tandem with the documentation of a monkeypox (mpox) incidence, combined with a vaccine shortage for the disease. This pronounced alert is relevant to both private healthcare institutions and government-operated hospitals.
Following the diagnosis confirmation by the Federal Health Ministry, a new mpox strain has engendered international apprehension due to its seemingly easier transmission potential via conventional close contact. This infection flare can be traced back to an escalating epidemic in Africa and has since been evidenced in Sweden – marking its inaugural manifestation beyond the African continent.
Monkeypox shares similarities with the now-eradicated smallpox virus. According to the World Health Organization, it is easily transmitted through direct contact and polluted materials such as clothing, bed linens, and needles. Conversely, the type of the patient’s mpox strain will remain indeterminate until the genomic sequencing procedure is completed.
In a recent revision, Khyber Pakhtunkhwa health authorities verified one mpox case, rescinding their former declaration of detecting three cases. The experts emphasize the importance of maintaining strict hygiene practices such as wearing N-95 masks to prevent mpox transmission, which can be diagnosed via a polymerase chain reaction (PCR) test. Despite mpox vaccine’s ability to convey some immunity against the disease, vaccine shortages have been reported. Signature symptoms of mpox include fever, muscle pain, gland swelling, exhaustion, and headache, serving as precursors to a painful skin eruption that eventually resolves.
The CDC has reported varying death rates across outbreaks, with some up to 10%, whereas more recent ones showcase lesser figures. Severe infection risks escalate among infants, immunocompromised individuals, and pregnant women. Reportedly, the WHO has documented over 99,000 mpox cases across 116 countries between January 2022 and June 2024, leading to 208 deaths. A majority of these cases originate from Africa, followed by the Americas, and Europe. The latest surge has predominantly involved the deadlier clade 1 variant and its recent mutation.